Profile
AFIB ABT BSX-PA SYK MDT BSX
Company Name Acutus Medical, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $5.98K $194.01B $175.45B $139.91B $129.39B $109.92B
Employees 0.09K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Takeo Mukai Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
AFIB ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
AFIB ABT BSX-PA SYK MDT BSX
Last Close $0.0005 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $0.07 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 - $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -99.29 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 0 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
AFIB ABT BSX-PA SYK MDT BSX
1 Month Return 0 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 66.67 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return -98.39 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -98.98 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -99 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -99.17 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AFIB ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.15 % - 0.93 % 2.81 % -
Dividend Paid and Capex Coverage Ration (TTM) -250.19 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Profitability
AFIB ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 11.1 % 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -24.48 % 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM 64.07 % 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM 1.34 % 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 330.96 % 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM -976.5 % 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM 1.75 % 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -21.69 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 1.57 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 8.64 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM 6.16 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 416.83 % 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 43.3 % 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -0.26 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -0.26 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 47.09 % 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -62.52 % 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.6 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -21.69 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM - 28.05 29.17 32.67 24.85 29.12
Price To Operating Cash Flows Ratio TTM - 21.36 23.8 27.74 18.18 23.76
Price Cash Flow Ratio TTM - 21.36 23.8 27.74 18.18 23.76
Income Statement (TTM)
AFIB ABT BSX-PA SYK MDT BSX
Revenue $0.02B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 5.03% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $0B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -0.32 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
AFIB ABT BSX-PA SYK MDT BSX
Long Term Debt $0.03B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.04B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $-0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0.04B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.03B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
AFIB ABT BSX-PA SYK MDT BSX
Net Income $-0B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.03B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.18
ADGM Adagio Medical Holdings, Inc. 1.0162
AEMD Aethlon Medical, Inc. 1.93
AHCO AdaptHealth Corp. 10.065
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 185.225
ALUR Allurion Technologies Inc. 1.06
AMIX Autonomix Medical, Inc. Common Stock 0.388
ANIK Anika Therapeutics, Inc. 9.9668
AORT Artivion, Inc. 36.98
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.775
ARAY Accuray Incorporated 0.559
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.32
AVNS Avanos Medical, Inc. 14.92
AVR Anteris Technologies Global Corp. Common Stock 5.52
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 33.425
ETFs With Exposure to AFIB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 335.56
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 148.71
VXF Vanguard Extended Market Index Fund 0 214.255
VFLQ Vanguard U.S. Liquidity Factor ETF 0.04 99.7611
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 162.32
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 162.33
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 400.57
Unlock